Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth

Delgado-Calle, J ; Anderson, J ; Cregor, M D ; Condon, K W ; Kuhstoss, S A ; Plotkin, L I ; Bellido, T ; Roodman, G D

Leukemia, 2017-12, Vol.31 (12), p.2686-2694 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível